Stocks

Magazine articles on individual stocks, valuation, accounting standards, IPO's, brokerages, exchanges.

Old Articles: <Older 21911-21920 Newer>

The Motley Fool March 30, 2007	Time to Watch Movado?: Fool by Numbers The watch maker released fourth-quarter 2007 earnings: Income Statement Highlights... Margin Checkup... Balance Sheet Highlights... Cash Flow Highlights...
BusinessWeek April 9, 2007 Gene G. Marcial	Hail To CVS/Caremark Deal or no deal, CVS was already a fave on Wall Street. And now that it has acquired Caremark Rx, No.2 in pharmacy-benefits management, Goldman Sachs, UBS, and Matrix USA are even more bullish.
BusinessWeek April 9, 2007 Gene G. Marcial	Exponent: A Rising Power In Consulting? Exponent is a real problem solver. Its stock, reflecting the small outfit's success, has bolted.
BusinessWeek April 9, 2007 Gene G. Marcial	Acorda Tackles Multiple Sclerosis A Corda Therapeutics isn't your typical biotech.
The Motley Fool March 29, 2007 Jack Uldrich	New Kid on the Farm: Cellulosic Ethanol The technology may not be ready until 2009, but investors should take note today.
The Motley Fool March 29, 2007	Resources Connection Falls Short: Fool by Numbers The professional services firm released third-quarter 2007 earnings: Income Statement Highlights... Margin Checkup... Balance Sheet Highlights... Cash Flow Highlights...
The Motley Fool March 29, 2007 Dan Caplinger	What's in a Ticker? Ticker symbols have a hierarchy all their own. In the end, of course, ticker symbols have little to do with a business's success.
The Motley Fool March 29, 2007 Brian Lawler	Genentech Going Forward Genentech gives guidance for first-quarter sales numbers. Investors, take note.
The Motley Fool March 29, 2007 Emil Lee	IPG Puts Its Best Foot Forward The advertising and marketing agency has momentum, a strong stable of brands, and a very healthy balance sheet. All in all, it's got a pretty good shot at getting back on track. Investors, take note.
The Motley Fool March 29, 2007 Dan Bloom	Is Trident Worth 8.6 Times Sales? Investors better hope that its chips can keep the competition at bay. This could be a risky stock for investors.
<Older 21911-21920 Newer> Return to current articles.